Personalized medicine breakthrough for childhood leukemia

2 days ago 2
Researchers from Newcastle University and Great Ormond Street Hospital person identified caller predictors of relapse successful children and young radical with acute lymphoblastic leukemia (ALL) treated with the immunotherapy cause blinatumomab, arsenic portion of a U.K.-wide study.
Read Entire Article